Skip to main content

Table 4 Linear multivariate analyses using (A) lipid index and (B) fibrous cap thickness as the dependent variable, (1) In all patients (n = 166), (2) in DM patients (n = 83), and (3) in non-DM patient (n = 83)

From: Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography

(1) in all patients
(A)
Variables Non-standardized coefficients Standardized coefficients β t P value
B SE
MAGE 31.9 4.239 0.527 7.541 <0.001
Mean BG 10.4 5.075 0.143 2.051 0.042
(B)
MAGE −0.868 0.171 −0.392 −5.076 <0.001
Time in hypoglycemia −3.789 1.828 −0.160 −0.160 0.040
(2) in DM groups
(A)
MAGE 35.0 6.554 0.515 5.346 <0.001
(B)
MAGE −0.906 0.212 −0.433 −4.265 <0.001
(3) in non-DM patients
(A)
MAGE 31.9 5.633 0.532 5.661 <0.001
(B)
MAGE −1.357 0.280 −0.474 −4.847 <0.001
  1. BG: blood glucose; MAGE: mean amplitude of glycemic excursion